CVS to Remove Humira From Some Reimbursement Lists in Favor of Biosimilar Options

Starting April 1, 2024, Hyrimoz and an unbranded version of Humira manufactured by Sandoz will be covered across all CVS formularies.

Source link
#CVS #Remove #Humira #Reimbursement #Lists #Favor #Biosimilar #Options